Cardiovascular disease is a general term that refers to many different types of heart problems. Heart disease is the No. 1 ...

Lupin announced that it has launched Rivaroxaban tablets USP, 2.5 mg, in the US market following final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug ...

Lupin's shares increased by 21.51% over the past year. However, year-to-date (YTD), the stock has decreased by 14.21%. Over ...

A study published March 6 in The Lancet Regional Health - Americas highlights a growing divide in cardiovascular health in the U.S., showing that wealth and education play a significant role in heart ...

Are you experiencing leg pain, numbness, or slow-healing wounds? 🦵 These could be warning signs of Peripheral Artery Disease ...

Americas highlights a growing divide in cardiovascular health in the U.S., showing that wealth and education play a ...

Peripheral artery disease, also known as PAD, is a condition in which the narrowing of the arteries causes poor blood flow to ...

Trestle Biotherapeutics, Inc., today announced a research collaboration with Humacyte, Inc. (Nasdaq: HUMA), a ...

A recent study finds that nonmalignant gynecological diseases are associated with cardiovascular and/or cerebrovascular disease.

Johnson & Johnson MedTech‘s Shockwave Medical announced the U.S. launch of its Javelin peripheral intravascular lithotripsy ...

The FDA approved the first generics of the direct oral anticoagulant rivaroxaban, the agency announced on Tuesday.

Johnson & Johnson MedTech’s Shockwave Medical is launching a new intravascular lithotripsy catheter in the U.S. | While ...